Pharmafile Logo
Pharmafocus logo
Advanced Search

Cancer

Showing 15 posts of 1067 posts found.

Merck image

Merck seeks new Keytruda indication in US

April 20, 2015
Sales and Marketing Cancer, FDA, NSCLC, PD-L1, US, keytruda, lung, pembrolizumab

Merck is seeking FDA approval for its successful melanoma drug Keytruda to be used treating lung cancer. The Supplemental Biologics …

News
Astrazeneca image

AstraZeneca bags another FDA orphan status in cancer

April 17, 2015
Sales and Marketing AstraZeneca, Cancer, FDA, GlaxoSmithKline, mekinist, melanoma, oncology, selumetinib, trametinib

The FDA has granted AstraZeneca’s cancer medicine selumetinib orphan drug designation for the treatment of uveal melanoma. The company will …

News
Sun Pharmaceutical Industries, India

Sun Pharma and Technion form oncology research pact

April 16, 2015
Research and Development, Sales and Marketing Cancer, Sun Pharma, institute of technology, oncology, technion

Mumbai-based Sun Pharmaceuticals Industries is teaming up with the Israel Institute of Technology Technion to develop new oncology drugs. This …

News
arzerra image

Trial results back NICE decision on Novartis cancer drug

April 15, 2015
Sales and Marketing Arzerra, Cancer, NHS, NICE, chemo, chlorambucil, fludarabine, leukaemia, ofatumumab

Treatment with Arzerra improves survival in people with chronic lymphocytic leukaemia (CLL) according to study results that back NICE’s decision …

News
xalkori

Merck and Pfizer to co-promote cancer drug

April 9, 2015
Research and Development, Sales and Marketing Cancer, Merck, Merck KGaA, NSCLC, Pfizer, Xalkori, non-small cell lung cancer, oncology

Merck KgaA and Pfizer have agreed to co-promote the latter’s lung cancer treatment Xalkori, and form a new alliance that …

News
Avastin image

EU nod for Roche cancer drug and chemotherapy

April 8, 2015
Sales and Marketing Cancer, Roche, avastin, bevacizumab, cervical, chemotherapy, wet AMD

The European Commission has approved Roche’s Avastin in combination with standard chemotherapy for women with advanced cervical cancer.  Avastin (bevacizumab) …

News
Actos image

Takeda offers $2.2 billion to resolve Actos damages claims

April 1, 2015
Sales and Marketing Actos, Cancer, Takeda, bladder, diabetes, heart, pioglitazone

Takeda has attempted to settle its hefty damages bill over claims it was hiding cancer risks in its diabetes drug …

News
Merck image

Merck lines up early-stage Keytruda combo trial

April 1, 2015
Research and Development, Sales and Marketing Cancer, Merck, entinostat, keytruda, pd1, pembrolizumab, syndax

Merck is planning for Keytruda’s future by launching early-stage trials of the drug in combination with an investigational treatment from …

News

Novartis in major oncology drive

March 30, 2015
Research and Development, Sales and Marketing Cancer, FDA, MHRA, Novartis, aduro, ceritinib, eams, early access, zykadia

Novartis says it is ‘stepping up its efforts’ in cancer by launching major initiatives to discover new treatments to combat …

News
Velcade image

J&J blood cancer drug gets UK launch

March 25, 2015
Sales and Marketing Cancer, J&J, JJ, Janssen, NICE, Velcade, bortezomib, mcl, nhl

Johnson and Johnson’s pharma unit Janssen is launching Velcade in the UK for the first-line treatment of Mantle Cell Lymphoma …

News
FDA image

FDA lifts ban on Pfizer Lilly pain study

March 24, 2015
Research and Development, Sales and Marketing Cancer, FDA, Pfizer, lilly, pain, tanezumab

Pfizer and Eli Lilly will resume Phase III clinical trials of tanezumab following the FDA lifting a ban on trials …

News
Google image

Google files patent for cancer combating wearable

March 23, 2015
Medical Communications, Sales and Marketing Cancer, Nanoparticle Phoresis, google, google x, nano, oncology, wearable, wipo

Google has filed a patent application for a new cancer-fighting wearable device which it says targets the cells in the …

News
Jakavi image

Novartis blood cancer drug given EU nod

March 17, 2015
Sales and Marketing Cancer, EU, Jakavi, Novartis, oncology, polycythemia vera, ruxolitinib

Novartis’ blood cancer drug Jakavi has been given the green light in Europe to treat adult patients with polycythemia vera …

News
NHS image

NHS is struggling to improve cancer care

March 16, 2015
Sales and Marketing CRUK, Cancer, Department of Health, NHS, NHS England, oncology

The Department of Health and NHS England are struggling with the demand required to improve its cancer services according to …

News
Keytruda image

Merck’s cancer drug sees first ever early access nod

March 11, 2015
Sales and Marketing Cancer, ICR, Merck, eams, early access, keytruda, melanoma, oncology, pembrolizumab

Merck’s skin cancer drug Keytruda has become the first drug to be approved through the new Early Access to Medicines …

News
The Gateway to Local Adoption Series

Latest content

Just – Evotec given Gates Foundation grant to increase global biotherapeutics access

January 8, 2026

Johnson & Johnson submits robotic surgical system for De Novo classification

January 8, 2026

EA Pharma announces phase 3 trial for new schizophrenia treatment in Japan

January 7, 2026

Eleva appoints Erich Rajkovic as Chief Business Officer

January 7, 2026

MedPharm announces US FDA inspection of North Carolina manufacturing facility

January 6, 2026